Human Insulin - Global Strategic Business Report

Global Human Insulin Market to Reach $79.1 Billion by 2030

The global market for Human Insulin estimated at US$43 Billion in the year 2022, is projected to reach a revised size of US$79.1 Billion by 2030, growing at a CAGR of 7.9% over the analysis period 2022-2030. HI Drugs, one of the segments analyzed in the report, is projected to record 7.8% CAGR and reach US$70.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the HI Delivery Devices segment is readjusted to a revised 9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $11.7 Billion, While China is Forecast to Grow at 12.8% CAGR

The Human Insulin market in the U.S. is estimated at US$11.7 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$18.9 Billion by the year 2030 trailing a CAGR of 12.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.6% and 6.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Select Competitors (Total 43 Featured) -

• Becton, Dickinson and Company
• Biocon Limited
• Biodel, Inc.
• Boehringer Ingelheim International GmbH
• Boston Scientific Corp.
• Braun Melsungen AG
• ELI Lilly and Company
• Julphar (Also Known as Gulf Pharmaceutical Industries)
• Medtronic Plc
• Merck & Co., Inc.
• NOVO Nordisk A/S
• Sanofi
• Tonghua Dongbao Pharmaceutical
• Wockhardt Limited
• Ypsomed AG

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year